GlassScriptPhysician profile
Connie Hill
NPI 1477705507
$6,579.85
in general payments reported to CMS, 2019-2025
15 companies · $2,996 in 2025
The $2,996 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.95 · 2022: $2,131 · 2023: $702 · 2024: $690 · 2025: $2,996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,742 · Travel and Lodging: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,742.43 |
| Travel and Lodging | $646.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,863.70 | 2025 | |
| Boston Scientific Corporation | $1,844.00 | 2021-2025 | Eluvia, General - Vascular Intervention, Avvigo Guidance System |
| Intuitive Surgical, INC. | $934.23 | 2022 | |
| Edwards Lifesciences Corporation | $664.29 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $262.95 | 2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Ensite Precision |
| Atricure, INC. | $237.87 | 2025 | Synergy Ablation System, Epi-Ease Epicardial Access System |
| Livanova USA, INC. | $131.76 | 2023 | Lifesparc |
| Haemonetics Corporation | $126.83 | 2023 | Teg6s Hemostasis System |
| Cvrx, INC. | $121.32 | 2024 | Barostim Neo System |
| Biosense Webster, INC. | $89.50 | 2024 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $88.72 | 2024 | Farxiga |
| Amgen INC. | $86.54 | 2022 | |
| Novartis Pharmaceuticals Corporation | $60.20 | 2022-2025 | |
| Mindray Ds USA, INC. | $36.83 | 2023 | Na Electrode,Indirect,International, Patient Monitor |
| Angiodynamics, INC. | $31.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.